SillaJen Announces Collaboration with the National Cancer Institute for Development of Combination


We welcome the opportunity to collaborate with Dr. Greten in the development of this promising combination therapy, said Eun Sang Moon, chief executive officer of SillaJen. Dr. Greten is Senior Investigator in the Thoracic and Gastrointestinal Oncology Branch of NCI s Center for Cancer research and an expert in GI Oncology and tumor immunology.  Dr. Greten [ ] The post SillaJen Announces Collaboration with the National Cancer Institute for Development of Combination appeared first on STL News.
http://bit.ly/2uKxqej

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s